Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity

Retrovirology

Volumn 8, Issue , 2011, Pages

  Hoorelbeke, Bart ^a   Van Damme, Els J M ^b   Rougé, Pierre ^c   Schols, Dominique ^a   Van Laethem, Kristel ^a   Fouquaert, Elke ^b   Balzarini, Jan ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CD4 ANTIGEN; GLYCOPROTEIN GP 120; MANNOSE OLIGOSACCHARIDE; MONOCLONAL ANTIBODY 2G12; N ACETYLGLUCOSAMINE; PLANT LECTIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LECTIN; MANNOSE;

ANTIBODY SPECIFICITY; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CD4+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPITOPE MAPPING; GALANTHUS; GALANTHUS NIVALIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAIZE; PROTEIN CARBOHYDRATE INTERACTION; SPECIES DIFFERENCE; SURFACE PLASMON RESONANCE; SYNCYTIUM; VIRION; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TRANSMISSION; CELL LINE; CHEMISTRY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; PATHOGENICITY; PROTEIN ANALYSIS; PROTEIN BINDING; VIROLOGY; VIRUS REPLICATION;

GALANTHUS NIVALIS; HUMAN IMMUNODEFICIENCY VIRUS 1; ZEA MAYS;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; EPITOPE MAPPING; GALANTHUS; HIV-1; HUMANS; KINETICS; LECTINS; MANNOSE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SURFACE PLASMON RESONANCE; VIRUS REPLICATION; ZEA MAYS;

EID: 79751524978     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-8-10     Document Type: Article

References (47)

1. Van Damme EJM, Lannoo N, Peumans WJ. Plant lectins. Adv Bot Res 2008, 48:107-209.
2. Van Damme EJM, Allen AK, Peumans WJ. Isolation and characterization of a lectin with exclusive specificity toward mannose from snowdrop (Galanthus nivalis) bulbs. FEBS Lett 1987, 215:140-144.
3. Tsutsui S, Tasumi S, Suetake H, Suzuki Y. Lectins homologous to those of monocotyledonous plants in the skin mucus and intestine of pufferfish, Fugu rubripes. J Biol Chem 2003, 278:20882-20889. 10.1074/jbc.M301038200, 12654913.
4. Parret AH, Schoofs G, Proost P, De Mot R. Plant lectin-like bacteriocin from a rhizosphere-colonizing Pseudomonas isolate. J Bacteriol 2003, 185:897-908. 10.1128/JB.185.3.897-908.2003, 142807, 12533465.
5. Parret AH, Temmerman K, De Mot R. Novel lectin-like bacteriocins of biocontrol strain Pseudomonas fluorescens Pf-5. Appl Environ Microbiol 2005, 71:5197-5207. 10.1128/AEM.71.9.5197-5207.2005, 1214683, 16151105.
6. Barre A, Van Damme EJM, Peumans WJ, Rougé P. Structure-function relationship of monocot mannose-binding lectins. Plant Physiol 1996, 112:1531-1540. 10.1104/pp.112.4.1531, 158086, 8972598.
7. Balzarini J, Schols D, Neyts J, Van Damme E, Peumans W, De Clercq E. Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro. Antimicrob Agents Chemother 1991, 35:410-416. 245024, 1645507.
8. Balzarini J, Hatse S, Vermeire K, Princen K, Aquaro S, Perno CF, De Clercq E, Egberink H, Vanden Mooter G, Peumans W, Van Damme E, Schols D. Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection. Antimicrob Agents Chemother 2004, 48:3858-3870. 10.1128/AAC.48.10.3858-3870.2004, 521907, 15388446.
9. Balzarini J. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat Rev Microbiol 2007, 5:583-597. 10.1038/nrmicro1707, 17632570.
10. Fouquaert E, Hanton SL, Brandizzi F, Peumans WJ, Van Damme EJM. Localization and topogenesis studies of cytoplasmic and vacuolar homologs of the Galanthus nivalis agglutinin. Plant Cell Physiol 2007, 48:1010-1021. 10.1093/pcp/pcm071, 17567639.
11. Fouquaert E, Smith DF, Peumans WJ, Proost P, Balzarini J, Savvides SN, Van Damme EJM. Related lectins from snowdrop and maize differ in their carbohydrate-binding specificity. Biochem Biophys Res Commun 2009, 380:260-265. 10.1016/j.bbrc.2009.01.048, 2681488, 19167365.
12. Shibuya N, Goldstein IJ, Van Damme EJM, Peumans WJ. Binding properties of a mannose-specific lectin from the snowdrop (Galanthus nivalis) bulb. J Biol Chem 1988, 263:728-734.
13. Loris R, Hamelryck T, Bouckaert J, Wyns L. Legume lectin structure. Biochem Biophys Acta 1998, 1383:9-36. 10.1016/S0167-4838(97)00182-9, 9546043.
14. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597. 10.1016/S0092-8674(00)80694-7, 10721995.
15. Balzarini J, Van Herrewege Y, Vermeire K, Vanham G, Schols D. Carbohydrate binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T-lymphocytes. Mol Pharmacol 2007, 71:3-11. 10.1124/mol.106.030155, 17056872.
16. Van Laethem K, Schrooten Y, Lemey P, Van Wijngaerden E, De Wit S, Van Ranst M, Vandamme AM. Genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1envelope gene. J Virol Methods 2005, 123:25-34. 10.1016/j.jviromet.2004.09.003, 15582695.
17. Hester G, Wright CS. The mannose-specific bulb lectin from Galanthus nivalis (snowdrop) binds mono- and dimannosides at distinct sites. Structure analysis of refined complexes at 2.3 Å and 3.0 Å resolution. J Mol Biol 1996, 262:516-31. 10.1006/jmbi.1996.0532, 8893860.
18. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res 2000, 28:235-242. 10.1093/nar/28.1.235, 102472, 10592235.
19. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tool. Nucleic Acids Res 1997, 15:4876-4882.
20. Gaboriaud C, Bissery V, Benchetrit T, Mornon JP. Hydrophobic cluster analysis: an efficient new way to compare and analyse amino acid sequences. FEBS Lett 1987, 224:149-155. 10.1016/0014-5793(87)80439-8, 3678489.
21. Ponder JW, Richards FM. Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes. J Mol Biol 1987, 193:775-791. 10.1016/0022-2836(87)90358-5, 2441069.
22. Mas MT, Smith KC, Yarmush DL, Aisaka K, Fine RM. Modeling the anti-CEA antibody combining site by homology and conformational search. Proteins Struc Func Genet 1992, 14:483-498.
23. Ramachandran GN, Sasisekharan V. Conformation of polypeptides and proteins. Adv Protein Chem 1968, 23:283-438. full_text, 4882249.
24. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemistry of protein structures. J Appl Cryst 1993, 26:283-291.
25. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF-Chemera - a visualization system for exploratory research and analysis. J Comput Chem 2004, 25:1605-1612. 10.1002/jcc.20084, 15264254.
26. Nicholls A, Sharp KA, Honig B. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struc Func Genet 1991, 11:281-296.
27. Gilson MK, Honig BH. Calculation of electrostatic potential in an enzyme active site. Nature 1987, 330:84-86. 10.1038/330084a0, 3313058.
28. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990, 265:10373-10382.
29. Cummings RD, Etzler ME. Antibodies and lectins in glycan analysis. Essentials of Glycobiology 2009, 633-647. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, 2.
30. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, Peumans WJ. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem 1987, 262:1596-1601.
31. Valenzuela A, Blanco J, Krust B, Franco R, Hovanessian AG. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells. J Virol 1997, 71:8289-8298. 192287, 9343181.
32. Ghiara JB, Stura EA, Stanfield RL, Profy AT, Wilson IA. Crystal structure of the principal neutralization site of HIV-1. Science 1994, 264:82-85. 10.1126/science.7511253, 7511253.
33. Ghiara JB, Ferguson DC, Satterthwait AC, Dyson HJ, Wilson IA. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site. J Mol Biol 1997, 266:31-39. 10.1006/jmbi.1996.0768, 9054968.
34. Cutalo JM, Deterding LJ, Tomer KB. Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry. J Am Soc Mass Spectrom 2004, 15:1545-1555. 10.1016/j.jasms.2004.07.008, 1351241, 15519221.
35. Balzarini J, Van Laethem K, Hatse S, Froeyen M, Van Damme E, Bolmstedt A, Peumans W, De Clercq E, Schols D. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis. Mol Pharmacol 2005, 67:1556-1565. 10.1124/mol.104.005082, 15718224.
36. Balzarini J, Van Laethem K, Hatse S, Vermeire K, De Clercq E, Peumans W, Van Damme E, Vandamme AM, Bolmstedt A, Schols D. Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins. J Virol 2004, 78:10617-10627. 10.1128/JVI.78.19.10617-10627.2004, 516383, 15367629.
37. Tanaka H, Chiba H, Inokoshi J, Kuno A, Sugai T, Takahashi A, Ito Y, Tsunoda M, Suzuki K, Takénaka A, Sekiguchi T, Umeyama H, Hirabayashi J, Omura S. Mechanism by which the lectin actinohivin blocks HIV infection of target cells. Proc Natl Acad Sci USA 2009, 106:15633-15638. 10.1073/pnas.0907572106, 2734881, 19717426.
38. Hoorelbeke B, Huskens D, Férir G, François KO, Takahashi A, Van Laethem K, Schols D, Tanaka H, Balzarini J. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose type glycans on the gp120 envelope. Antimicrob Agents Chemother 2010, 54:3287-3301. 10.1128/AAC.00254-10, 2916299, 20498311.
39. Balzarini J, Van Laethem K, Peumans WJ, Van Damme EJ, Bolmstedt A, Gago F, Schols D. Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes. J Virol 2006, 80:8411-8421. 10.1128/JVI.00369-06, 1563877, 16912292.
40. Huskens D, Van Laethem K, Vermeire K, Balzarini J, Schols D. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12. Virology 2007, 360:294-304. 10.1016/j.virol.2006.10.027, 17123566.
41. Balzarini J, Van Laethem K, Daelemans D, Hatse S, Bugatti A, Rusnati M, Igarashi Y, Oki T, Schols D. Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus. J Virol 2007, 81:362-373. 10.1128/JVI.01404-06, 1797273, 17050611.
42. Balzarini J, François K, Van Laethem K, Hoorelbeke B, Renders M, Auwerx J, Liekens S, Oki T, Igarashi Y, Schols D. Pradimicin S, a highly-soluble non-peptidic small-size carbohydrate-binding antibiotic, is an anti-HIV drug lead for both microbicidal and systemic use. Antimicrob Agents Chemother 2010, 54:1425-1435. 10.1128/AAC.01347-09, 2849379, 20047920.
43. Scanlan CN, Pantophlet R, Wormald MR, Ollmann SE, Stanfield R, Wilson IA, Katinger H, Dwek RA, Rudd PM, Burton DR. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α(1-2) mannose residues on the outer face of gp120. J Virol 2002, 76:7306-7321. 10.1128/JVI.76.14.7306-7321.2002, 136327, 12072529.
44. Doores KJ, Bonomelli C, Harvey DJ, Vasiljevic S, Dwek RA, Burton DR, Crispin M, Scanlan CN. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc Natl Acad Sci USA 2010, 107:13800-13805. 10.1073/pnas.1006498107, 2922250, 20643940.
45. Trippier PC, McGuigan C. Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications. Med Chem Commun 2010, 1:183-198.
46. Jay JI, Lai BE, Myszka DG, Mahalingam A, Langheinrich K, Katz DF, Kiser PF. Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors. Mol Pharmacol 2010, 7:116-129.
47. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393:648-659. 10.1038/31405, 9641677.